Bank of America
NYMX

Bank of America’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Bank of America’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-708
Closed -$134 – 8155
2023
Q2 		$134 Hold
708
– – ﹤0.01% 7404
2023
Q1 		$240 Buy
708
+354
+100% +$144 ﹤0.01% 7418
2022
Q4 		$114 Sell
354
-912
-72% -$330 ﹤0.01% 7649
2022
Q3 		$1K Sell
1,266
-1,982
-61% -$788 ﹤0.01% 7732
2022
Q2 		$1K Sell
3,248
-6,153
-65% -$5.66K ﹤0.01% 7923
2022
Q1 		$12K Sell
9,401
-5,716
-38% -$8.83K ﹤0.01% 7691
2021
Q4 		$20K Sell
15,117
-7,166
-32% -$11.4K ﹤0.01% 7529
2021
Q3 		$46K Sell
22,283
-7,664
-26% -$13.6K ﹤0.01% 7092
2021
Q2 		$47K Sell
29,947
-57,445
-66% -$106K ﹤0.01% 6870
2021
Q1 		$194K Buy
87,392
+50,454
+137% +$133K ﹤0.01% 6065
2020
Q4 		$92K Buy
36,938
+9,938
+37% +$22K ﹤0.01% 6031
2020
Q3 		$66K Sell
27,000
-50,499
-65% -$147K ﹤0.01% 5894
2020
Q2 		$275K Buy
77,499
+10,845
+16% +$34.3K ﹤0.01% 5033
2020
Q1 		$156K Sell
66,654
-42,110
-39% -$118K ﹤0.01% 5249
2019
Q4 		$239K Sell
108,764
-19,437
-15% -$38.4K ﹤0.01% 5523
2019
Q3 		$235K Sell
128,201
-84,087
-40% -$147K ﹤0.01% 5569
2019
Q2 		$308K Buy
212,288
+78,897
+59% +$138K ﹤0.01% 5390
2019
Q1 		$263K Sell
133,391
-15,052
-10% -$31.9K ﹤0.01% 5390
2018
Q4 		$195K Buy
148,443
+83,925
+130% +$154K ﹤0.01% 5531
2018
Q3 		$158K Buy
64,518
+5,895
+10% +$17.4K ﹤0.01% 5618
2018
Q2 		$197K Buy
58,623
+50,792
+649% +$195K ﹤0.01% 5420
2018
Q1 		$33K Sell
7,831
-1,921
-20% -$6.66K ﹤0.01% 6210
2017
Q4 		$32K Buy
9,752
+3,034
+45% +$11.1K ﹤0.01% 6259
2017
Q3 		$26K Sell
6,718
-2,336
-26% -$8.86K ﹤0.01% 6179
2017
Q2 		$40K Hold
9,054
– – ﹤0.01% 5967
2017
Q1 		$33K Buy
9,054
+3,754
+71% +$12.4K ﹤0.01% 6110
2016
Q4 		$14K Hold
5,300
– – ﹤0.01% 6466
2016
Q3 		$17K Sell
5,300
-5,000
-49% -$16.4K ﹤0.01% 6198
2016
Q2 		$35K Sell
10,300
-3,754
-27% -$9.22K ﹤0.01% 5994
2016
Q1 		$34K Sell
14,054
-10,000
-42% -$23.6K ﹤0.01% 5926
2015
Q4 		$79K Buy
24,054
+10,000
+71% +$33.5K ﹤0.01% 5841
2015
Q3 		$48K Buy
14,054
+2,754
+24% +$6.41K ﹤0.01% 5964
2015
Q2 		$15K Buy
11,300
+1,000
+10% +$1.4K ﹤0.01% 6459
2015
Q1 		$9K Hold
10,300
– – ﹤0.01% 6334
2014
Q4 		$4K Sell
10,300
-3,000
-23% -$6.4K ﹤0.01% 7353
2014
Q3 		$58K Buy
13,300
+3,000
+29% +$14.7K ﹤0.01% 6401
2014
Q2 		$51K Hold
10,300
– – ﹤0.01% 6643
2014
Q1 		$56K Sell
10,300
-2,500
-20% -$14.5K ﹤0.01% 6354
2013
Q4 		$78K Buy
12,800
+2,500
+24% +$17K ﹤0.01% 6296
2013
Q3 		$68K Hold
10,300
– – ﹤0.01% 6234
2013
Q2 		$52K Buy
+10,300
New +$52.2K ﹤0.01% 6535

Other funds holding NYMX

DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
FCFC
First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return
CAM
Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return
ODIJL
One Day In July LLC Burlington, Vermont $1.44B AUM 17.18% 1-Year Est. Return

Bank of America's NYMX Position: Q3 2023 in Review

Bank of America sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2023, closing a stake of 708 shares — an estimated $134 sold.

Bank of America first reported a position in NYMX in Q2 2013 and held it in 41 quarters. The position peaked at $308K in Q2 2019. 5 funds tracked by Wall St. Rank hold NYMX as of Q3 2023.

  • Bank of America reported no remaining Nymox Pharmaceutical Corp position as of Q3 2023 after selling out during the quarter.
  • Bank of America sold 708 Nymox Pharmaceutical Corp shares in Q3 2023, an estimated $134.
  • Bank of America first reported a position in Nymox Pharmaceutical Corp in Q2 2013 and held it in 41 quarters.
  • Bank of America's Nymox Pharmaceutical Corp position peaked at $308K in Q2 2019.
  • 5 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2023.

Based on Bank of America's 13F filing for Q3 2023, filed 14 Nov 2023.